AGEN•benzinga•
Agenus Announces New Data From Ongoing Phase 1 Trial Evaluating BOT/BAL In Patients With MSS mCRC At 2025 ESMO Gastrointestinal Cancers Congress
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 15, 2025 by benzinga